Amexdrug Corp. (AXRX) Financial Statements (2024 and earlier)

Company Profile

Business Address 369 SOUTH DOHENY DR SUITE 326
BEVERLY HILLS, CA 90211
State of Incorp. CA
Fiscal Year End December 31
Industry (SIC) 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments131 
Cash and cash equivalents126 
Short-term investments5 
Receivables640 
Inventory, net of allowances, customer advances and progress billings833
Inventory833 
Prepaid expense 
Other undisclosed current assets11 
Total current assets:1,616 
Noncurrent Assets
Property, plant and equipment474 
Intangible assets, net (including goodwill)18
Goodwill18 
Deposits noncurrent assets 30 
Other undisclosed noncurrent assets(473) 
Total noncurrent assets:48 
Other undisclosed assets474 
TOTAL ASSETS:2,138 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities397 
Taxes payable2 
Accounts payable387 
Accrued liabilities8 
Debt648 
Other undisclosed current liabilities177 
Total current liabilities:1,222 
Noncurrent Liabilities
Long-term debt and lease obligation315 
Long-term debt, excluding current maturities315 
Total noncurrent liabilities:315 
Total liabilities:1,537 
Equity
Equity, attributable to parent601 
Common stock169 
Treasury stock, value(16) 
Additional paid in capital(78) 
Retained earnings525 
Total equity:601 
TOTAL LIABILITIES AND EQUITY:2,138 

Income Statement (P&L) ($ in thousands)

6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Revenues2,361 
Cost of revenue
(Cost of Goods and Services Sold)
(1,842) 
Gross profit:519 
Operating expenses(243) 
Other undisclosed operating loss(18) 
Operating income:258 
Nonoperating expense(8) 
Other nonoperating expense(8) 
Interest and debt expense8 
Income from continuing operations before equity method investments, income taxes:258 
Other undisclosed loss from continuing operations before income taxes(8) 
Income from continuing operations before income taxes:250 
Income tax expense(78) 
Income from continuing operations:172 
Income before gain (loss) on sale of properties:172 
Net income available to common stockholders, diluted:172 

Comprehensive Income ($ in thousands)

6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Net income:172 
Comprehensive income, net of tax, attributable to parent:172 

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: